Gene · 345611
Papers1,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A genetically encoded reporter reveals interferon responses in multiple cell lineages. | bioRxiv | 2026 | 41542457 | PubTator, text mining | PubMed |
| Nutrigenomics and Epigenetics in the Dietary Management of Inflammatory Bowel Diseases. | Genes (Basel) | 2025 | 41300823 | PubTator, text mining | PubMed |
| Radiotherapy-Related Autophagy Genes Predict Prognosis and Reveal Immunoscape Features and Immunotherapeutic Agents in Colorectal Cancer Patients. | J Environ Pathol Toxicol Oncol | 2025 | 41213063 | PubTator, text mining | PubMed |
| Neuroprotective effects of Berberine-loaded BMSCs-apoptotic extracellular vesicles on retinal ganglion cells: therapeutic potential for glaucomatous injury. | J Nanobiotechnology | 2025 | 41074006 | PubTator, text mining | PubMed |
| Emerging concepts and shifting paradigms for understanding the microbial basis of inflammatory bowel diseases. | J Clin Invest | 2025 | 40892512 | PubTator, text mining | PubMed |
| Targeting Irgm1 to combat osteoporosis: suppressing ROS and restoring bone remodeling. | Cell Death Dis | 2025 | 40866352 | PubTator, text mining | PubMed |
| Role of IRGM in acute lung injury: Inducing mitophagy and inactivating cGAS-STING signaling to improve lipopolysaccharide-induced alveolar epithelial barrier dysfunction. | Prostaglandins Other Lipid Mediat | 2025 | 40850438 | PubTator, text mining | PubMed |
| Main genetic factors associated with inflammatory bowel diseases and their consequences on intestinal permeability: involvement in gut inflammation. | J Gastroenterol | 2025 | 40841786 | PubTator, text mining | PubMed |
| Multi-function of adipose-derived stem cells on gut disorder: from bench to bedside. | Stem Cell Res Ther | 2025 | 40830985 | PubTator, text mining | PubMed |
| Outlier maternal haplogroups N5 and X2 and their potential role in elevated tuberculosis prevalence among the Sahariya tribe. | Mitochondrion | 2025 | 40829724 | PubTator, text mining | PubMed |
| Cytotoxic granules and effector molecules from immune cells in tuberculosis: Mechanisms of host defense and therapeutic potential. | Virulence | 2025 | 40825006 | PubTator, text mining | PubMed |
| Establishment of Coala: a novel 3D and 2D cancer cell line derived from colorectal cancer liver metastasis. | Hum Cell | 2025 | 40758205 | PubTator, text mining | PubMed |
| Association of polymorphisms and abnormal methylation of several autophagy genes with pulmonary tuberculosis susceptibility, clinical manifestations in a Chinese population. | BMC Infect Dis | 2025 | 40691537 | PubTator, text mining | PubMed |
| Key immune regulators in retinal ischemia-reperfusion injury via RNA sequencing. | Int J Ophthalmol | 2025 | 40688775 | PubTator, text mining | PubMed |
| IRGM Inhibits the AKT/mTOR Signaling Pathway by Interacting with TRIM21 to Alleviate Sepsis-Induced Acute Lung Injury. | Inflammation | 2025 | 39994091 | PubTator, text mining | PubMed |
| Long non-coding RNA AK023617 orchestrates atherosclerosis by regulating the circadian rhythm of immunity-related GTPase family M protein in macrophages. | Noncoding RNA Res | 2025 | 39902258 | PubTator, text mining | PubMed |
Corrigendum to "A potential early-atheroprotective target: Irgm1 mediates lymphangiogenesis through LEC autophagy by Tfeb translocation" [Biochim. Biophys. Acta Mol. Basis Dis. volume 1870, issue 6, (2024) 167238]. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39665974 | PubTator, text mining | PubMed |
| Novel Targets for the Development of Tuberculosis Vaccine. | Curr Drug Discov Technol | 2025 | 38859789 | PubTator, text mining | PubMed |
| Total synthesis and target identification of marine cyclopiane diterpenes. | Nat Commun | 2024 | 39738095 | PubTator, text mining | PubMed |
| Neuron-specific deficiency of autophagy increases neuronal loss in traumatic brain injury. | PNAS Nexus | 2024 | 39474507 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/345611/papers?page=2